Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

208 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Characterization of genetic loci that affect susceptibility to inflammatory bowel diseases in African Americans.
Huang C, Haritunians T, Okou DT, Cutler DJ, Zwick ME, Taylor KD, Datta LW, Maranville JC, Liu Z, Ellis S, Chopra P, Alexander JS, Baldassano RN, Cross RK, Dassopoulos T, Dhere TA, Duerr RH, Hanson JS, Hou JK, Hussain SZ, Isaacs KL, Kachelries KE, Kader H, Kappelman MD, Katz J, Kellermayer R, Kirschner BS, Kuemmerle JF, Kumar A, Kwon JH, Lazarev M, Mannon P, Moulton DE, Osuntokun BO, Patel A, Rioux JD, Rotter JI, Saeed S, Scherl EJ, Silverberg MS, Silverman A, Targan SR, Valentine JF, Wang MH, Simpson CL, Bridges SL, Kimberly RP, Rich SS, Cho JH, Rienzo AD, Kao LWH, McGovern DPB, Brant SR, Kugathasan S. Huang C, et al. Among authors: cross rk. Gastroenterology. 2015 Nov;149(6):1575-1586. doi: 10.1053/j.gastro.2015.07.065. Epub 2015 Aug 14. Gastroenterology. 2015. PMID: 26278503 Free PMC article.
Nitric oxide in inflammatory bowel disease.
Cross RK, Wilson KT. Cross RK, et al. Inflamm Bowel Dis. 2003 May;9(3):179-89. doi: 10.1097/00054725-200305000-00006. Inflamm Bowel Dis. 2003. PMID: 12792224 Review.
Narcotic use in patients with Crohn's disease.
Cross RK, Wilson KT, Binion DG. Cross RK, et al. Am J Gastroenterol. 2005 Oct;100(10):2225-9. doi: 10.1111/j.1572-0241.2005.00256.x. Am J Gastroenterol. 2005. PMID: 16181373
Vedolizumab as induction and maintenance therapy for ulcerative colitis.
Feagan BG, Rutgeerts P, Sands BE, Hanauer S, Colombel JF, Sandborn WJ, Van Assche G, Axler J, Kim HJ, Danese S, Fox I, Milch C, Sankoh S, Wyant T, Xu J, Parikh A; GEMINI 1 Study Group. Feagan BG, et al. N Engl J Med. 2013 Aug 22;369(8):699-710. doi: 10.1056/NEJMoa1215734. N Engl J Med. 2013. PMID: 23964932 Free article. Clinical Trial.
Response to Kotze et al.
Flasar M, Syed A, Cross RK. Flasar M, et al. Among authors: cross rk. Am J Gastroenterol. 2014 Jan;109(1):139-40. doi: 10.1038/ajg.2013.379. Am J Gastroenterol. 2014. PMID: 24402544 No abstract available.
208 results